Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

High calories but not fat content of lard-based diet contribute to impaired mitochondrial oxidative phosphorylation in C57BL/6J mice heart.

Emelyanova L, Boukatina A, Myers C, Oyarzo J, Lustgarten J, Shi Y, Jahangir A.

PLoS One. 2019 Jul 2;14(7):e0217045. doi: 10.1371/journal.pone.0217045. eCollection 2019.

2.

Breed does not affect the association between murmur intensity and disease severity in dogs with pulmonic or subaortic stenosis.

Rishniw M, Caivano D, Dickson D, Swift S, Rouben C, Dennis S, Sammarco C, Lustgarten J, Ljungvall I.

J Small Anim Pract. 2019 Aug;60(8):493-498. doi: 10.1111/jsap.13015. Epub 2019 Apr 29.

PMID:
31032935
3.

Effects of a surgical checklist on decreasing incisional infections following foreign body removal from the gastrointestinal tract in dogs.

Launcelott ZA, Lustgarten J, Sung J, Samuels S, Davis S, Davis GJ.

Can Vet J. 2019 Jan;60(1):67-72.

4.

Learning Parsimonious Classification Rules from Gene Expression Data Using Bayesian Networks with Local Structure.

Lustgarten JL, Balasubramanian JB, Visweswaran S, Gopalakrishnan V.

Data (Basel). 2017 Mar;2(1). pii: 5. doi: 10.3390/data2010005. Epub 2017 Jan 18.

5.

An intrinsic CRF signaling system within the optic tectum.

Carr JA, Zhang B, Li W, Gao M, Garcia C, Lustgarten J, Wages M, Smith EE.

Gen Comp Endocrinol. 2013 Jul 1;188:204-11. doi: 10.1016/j.ygcen.2013.03.020. Epub 2013 Apr 9.

PMID:
23583471
6.

Intratumoral delivery of CpG-conjugated anti-MUC1 antibody enhances NK cell anti-tumor activity.

Schettini J, Kidiyoor A, Besmer DM, Tinder TL, Roy LD, Lustgarten J, Gendler SJ, Mukherjee P.

Cancer Immunol Immunother. 2012 Nov;61(11):2055-65. doi: 10.1007/s00262-012-1264-y. Epub 2012 Apr 28.

7.

Immunity, cancer and aging: lessons from mouse models.

Myers CE, Mirza NN, Lustgarten J.

Aging Dis. 2011 Dec;2(6):512-23. Epub 2011 Dec 2.

8.

A metaproteomic approach to study human-microbial ecosystems at the mucosal luminal interface.

Li X, LeBlanc J, Truong A, Vuthoori R, Chen SS, Lustgarten JL, Roth B, Allard J, Ippoliti A, Presley LL, Borneman J, Bigbee WL, Gopalakrishnan V, Graeber TG, Elashoff D, Braun J, Goodglick L.

PLoS One. 2011;6(11):e26542. doi: 10.1371/journal.pone.0026542. Epub 2011 Nov 21.

9.

Application of an efficient Bayesian discretization method to biomedical data.

Lustgarten JL, Visweswaran S, Gopalakrishnan V, Cooper GF.

BMC Bioinformatics. 2011 Jul 28;12:309. doi: 10.1186/1471-2105-12-309.

10.

Signals through 4-1BB inhibit T regulatory cells by blocking IL-9 production enhancing antitumor responses.

Smith SE, Hoelzinger DB, Dominguez AL, Van Snick J, Lustgarten J.

Cancer Immunol Immunother. 2011 Dec;60(12):1775-87. doi: 10.1007/s00262-011-1075-6. Epub 2011 Jul 26.

11.

Maximal T cell-mediated antitumor responses rely upon CCR5 expression in both CD4(+) and CD8(+) T cells.

González-Martín A, Gómez L, Lustgarten J, Mira E, Mañes S.

Cancer Res. 2011 Aug 15;71(16):5455-66. doi: 10.1158/0008-5472.CAN-11-1687. Epub 2011 Jun 29.

12.

Comparative kinetic analyses of gene profiles of naïve CD4+ and CD8+ T cells from young and old animals reveal novel age-related alterations.

Mirza N, Pollock K, Hoelzinger DB, Dominguez AL, Lustgarten J.

Aging Cell. 2011 Oct;10(5):853-67. doi: 10.1111/j.1474-9726.2011.00730.x. Epub 2011 Aug 7.

13.

Foxp3-positive macrophages display immunosuppressive properties and promote tumor growth.

Manrique SZ, Correa MA, Hoelzinger DB, Dominguez AL, Mirza N, Lin HH, Stein-Streilein J, Gordon S, Lustgarten J.

J Exp Med. 2011 Jul 4;208(7):1485-99. doi: 10.1084/jem.20100730. Epub 2011 Jun 13. Retraction in: J Exp Med. 2011 Nov 21;208(12):2561.

14.

The organization of CRF neuronal pathways in toads: Evidence that retinal afferents do not contribute significantly to tectal CRF content.

Carr JA, Lustgarten J, Ahmed N, Bergfeld N, Bulin SE, Shoukfeh O, Tripathy S.

Brain Behav Evol. 2010;76(1):71-86. doi: 10.1159/000319555. Epub 2010 Sep 30.

PMID:
20926857
15.

Fat tissue, aging, and cellular senescence.

Tchkonia T, Morbeck DE, Von Zglinicki T, Van Deursen J, Lustgarten J, Scrable H, Khosla S, Jensen MD, Kirkland JL.

Aging Cell. 2010 Oct;9(5):667-84. doi: 10.1111/j.1474-9726.2010.00608.x. Epub 2010 Aug 15. Review.

16.

Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics.

Ryberg H, An J, Darko S, Lustgarten JL, Jaffa M, Gopalakrishnan V, Lacomis D, Cudkowicz M, Bowser R.

Muscle Nerve. 2010 Jul;42(1):104-11. doi: 10.1002/mus.21683.

17.

Cancer immunotherapy: focusing on the young, neglecting the old.

Lustgarten J.

Future Oncol. 2010 Jun;6(6):873-6. doi: 10.2217/fon.10.64. No abstract available.

18.

Blockade of CCL1 inhibits T regulatory cell suppressive function enhancing tumor immunity without affecting T effector responses.

Hoelzinger DB, Smith SE, Mirza N, Dominguez AL, Manrique SZ, Lustgarten J.

J Immunol. 2010 Jun 15;184(12):6833-42. doi: 10.4049/jimmunol.0904084. Epub 2010 May 7.

19.

B7-H1 expression on old CD8+ T cells negatively regulates the activation of immune responses in aged animals.

Mirza N, Duque MA, Dominguez AL, Schrum AG, Dong H, Lustgarten J.

J Immunol. 2010 May 15;184(10):5466-5474. doi: 10.4049/jimmunol.0903561. Epub 2010 Apr 7.

20.

Bayesian rule learning for biomedical data mining.

Gopalakrishnan V, Lustgarten JL, Visweswaran S, Cooper GF.

Bioinformatics. 2010 Mar 1;26(5):668-75. doi: 10.1093/bioinformatics/btq005. Epub 2010 Jan 14.

21.

Targeting the tumor microenvironment with anti-neu/anti-CD40 conjugated nanoparticles for the induction of antitumor immune responses.

Dominguez AL, Lustgarten J.

Vaccine. 2010 Feb 3;28(5):1383-90. doi: 10.1016/j.vaccine.2009.10.153. Epub 2009 Nov 18.

22.

Alefacept for severe alopecia areata: a randomized, double-blind, placebo-controlled study.

Strober BE, Menon K, McMichael A, Hordinsky M, Krueger G, Panko J, Siu K, Lustgarten JL, Ross EK, Shapiro J.

Arch Dermatol. 2009 Nov;145(11):1262-6. doi: 10.1001/archdermatol.2009.264.

PMID:
19917955
23.

Impact of aging on cancer immunity and immunotherapy.

Pawelec G, Lustgarten J, Ruby C, Gravekamp C.

Cancer Immunol Immunother. 2009 Dec;58(12):1907-8. No abstract available.

PMID:
19787858
24.

Knowledge-based variable selection for learning rules from proteomic data.

Lustgarten JL, Visweswaran S, Bowser RP, Hogan WR, Gopalakrishnan V.

BMC Bioinformatics. 2009 Sep 17;10 Suppl 9:S16. doi: 10.1186/1471-2105-10-S9-S16.

25.

Cancer, aging and immunotherapy: lessons learned from animal models.

Lustgarten J.

Cancer Immunol Immunother. 2009 Dec;58(12):1979-89. doi: 10.1007/s00262-009-0677-8. Epub 2009 Feb 24. Review.

PMID:
19238382
26.

rAAV/Her-2/neu loading of dendritic cells for a potent cellular-mediated MHC class I restricted immune response against ovarian cancer.

Yu Y, Pilgrim P, Zhou W, Gagliano N, Frezza EE, Jenkins M, Weidanz JA, Lustgarten J, Cannon M, Bumm K, Cobos E, Kast WM, Chiriva-Internati M.

Viral Immunol. 2008 Dec;21(4):435-42. doi: 10.1089/vim.2008.0029.

PMID:
19115932
27.

Measuring stability of feature selection in biomedical datasets.

Lustgarten JL, Gopalakrishnan V, Visweswaran S.

AMIA Annu Symp Proc. 2009 Nov 14;2009:406-10.

28.

Using a novel resource to decrease proteomic biomarker identification time.

Lustgarten JL, Visweswaran S, Grover H, Kimmel CP, Ryberg H, Bowser RP, Gopalakrishnan V, Hogan WR.

AMIA Annu Symp Proc. 2008 Nov 6:1033.

PMID:
18999243
29.

Improving classification performance with discretization on biomedical datasets.

Lustgarten JL, Gopalakrishnan V, Grover H, Visweswaran S.

AMIA Annu Symp Proc. 2008 Nov 6:445-9.

30.

Successful devascularization of carotid body tumors by covered stent placement in the external carotid artery.

Scanlon JM, Lustgarten JJ, Karr SB, Cahan JI.

J Vasc Surg. 2008 Nov;48(5):1322-4. doi: 10.1016/j.jvs.2008.05.031.

31.

Systemic targeting of CpG-ODN to the tumor microenvironment with anti-neu-CpG hybrid molecule and T regulatory cell depletion induces memory responses in BALB-neuT tolerant mice.

Sharma S, Dominguez AL, Manrique SZ, Cavallo F, Sakaguchi S, Lustgarten J.

Cancer Res. 2008 Sep 15;68(18):7530-40. doi: 10.1158/0008-5472.CAN-08-1635.

32.

Implications of aging and self-tolerance on the generation of immune and antitumor immune responses.

Dominguez AL, Lustgarten J.

Cancer Res. 2008 Jul 1;68(13):5423-31. doi: 10.1158/0008-5472.CAN-07-6436.

33.

EPO-KB: a searchable knowledge base of biomarker to protein links.

Lustgarten JL, Kimmel C, Ryberg H, Hogan W.

Bioinformatics. 2008 Jun 1;24(11):1418-9. doi: 10.1093/bioinformatics/btn125. Epub 2008 Apr 9.

34.

CpG-ODN but not other TLR-ligands restore the antitumor responses in old mice: the implications for vaccinations in the aged.

Sharma S, Dominguez AL, Hoelzinger DB, Lustgarten J.

Cancer Immunol Immunother. 2008 Apr;57(4):549-61. Epub 2007 Sep 8.

PMID:
17828396
35.

High accumulation of T regulatory cells prevents the activation of immune responses in aged animals.

Sharma S, Dominguez AL, Lustgarten J.

J Immunol. 2006 Dec 15;177(12):8348-55.

36.

Levels of specific peptide-HLA class I complex predicts tumor cell susceptibility to CTL killing.

Weidanz JA, Nguyen T, Woodburn T, Neethling FA, Chiriva-Internati M, Hildebrand WH, Lustgarten J.

J Immunol. 2006 Oct 15;177(8):5088-97.

37.
38.

Aging affect the anti-tumor potential of dendritic cell vaccination, but it can be overcome by co-stimulation with anti-OX40 or anti-4-1BB.

Sharma S, Dominguez AL, Lustgarten J.

Exp Gerontol. 2006 Jan;41(1):78-84. Epub 2005 Nov 14.

PMID:
16289924
39.
40.

Novel syngeneic pseudo-orthotopic prostate cancer model: vascular, mitotic and apoptotic responses to castration.

Frost GI, Lustgarten J, Dudouet B, Nyberg L, Hartley-Asp B, Borgström P.

Microvasc Res. 2005 Jan;69(1-2):1-9.

PMID:
15797254
41.

Aged mice develop protective antitumor immune responses with appropriate costimulation.

Lustgarten J, Dominguez AL, Thoman M.

J Immunol. 2004 Oct 1;173(7):4510-5.

42.

Flagellin fusion proteins as adjuvants or vaccines induce specific immune responses.

Cuadros C, Lopez-Hernandez FJ, Dominguez AL, McClelland M, Lustgarten J.

Infect Immun. 2004 May;72(5):2810-6.

43.

The CD8+ T cell repertoire against Her-2/neu antigens in neu transgenic mice is of low avidity with antitumor activity.

Lustgarten J, Dominguez AL, Cuadros C.

Eur J Immunol. 2004 Mar;34(3):752-761. doi: 10.1002/eji.200324427.

45.

Cooperative effect between immunotherapy and antiangiogenic therapy leads to effective tumor rejection in tolerant Her-2/neu mice.

Cuadros C, Dominguez AL, Frost GI, Borgstrom P, Lustgarten J.

Cancer Res. 2003 Sep 15;63(18):5895-901.

46.

Anti-Her-2/neu-IL-2 or heregulin-IL-2 fusions proteins redirect non-tumor specific CTL to the tumor site for tumor eradication.

Lustgarten J.

Cancer Immunol Immunother. 2003 Dec;52(12):751-60. Epub 2003 Jun 19.

PMID:
12827309
47.

Redirecting effector T cells through their IL-2 receptors.

Lustgarten J, Marks J, Sherman LA.

J Immunol. 1999 Jan 1;162(1):359-65.

48.

Latanoprost treatment for glaucoma: effects of treating for 1 year and of switching from timolol. United States Latanoprost Study Group.

Camras CB, Wax MB, Ritch R, Weinreb R, Robin AL, Higginbotham EJ, Lustgarten J, Stewart WC, Sherwood M, Krupin T, Wilensky J, Cioffi GA, Katz LJ, Schumer RA, Kaufman PL, Minckler D, Zimmerman T, Stjernschantz J.

Am J Ophthalmol. 1998 Sep;126(3):390-9.

PMID:
9744372
49.

Tolerance to p53 by A2.1-restricted cytotoxic T lymphocytes.

Theobald M, Biggs J, Hernández J, Lustgarten J, Labadie C, Sherman LA.

J Exp Med. 1997 Mar 3;185(5):833-41.

50.

Identification of Her-2/Neu CTL epitopes using double transgenic mice expressing HLA-A2.1 and human CD.8.

Lustgarten J, Theobald M, Labadie C, LaFace D, Peterson P, Disis ML, Cheever MA, Sherman LA.

Hum Immunol. 1997 Feb;52(2):109-18.

PMID:
9077559

Supplemental Content

Loading ...
Support Center